Skip to main content
← All data ties

Biotech R&D (Except Nanobiotech) in California (NAICS 541714)

NAICS 541714 crossed with California produces $226,140,894.39 in USAspending.gov obligations on 333 awards. Research And Development In Biotechnology (Except Nanobiotechnology) is the industry label. The join is not nanobiotechnology R&D or a named California laboratory campus. Average obligation per award is about $679,101.78. Amounts are obligations, not outlays.

Key figures

  • NAICS 541714 in California: $226,140,894.39 across 333 USAspending awards.
  • Average obligation per award is about $679,101.78.
  • The pair is NAICS 541714 plus California, not nanobiotechnology R&D or a named California laboratory campus.
  • The total is obligations, not outlays; CA is place of performance.
  • FEC donations do not fund this USAspending cell.

The 541714 × California join

The relationship is mechanical: industry code 541714 and state CA on the same award roll into $226,140,894.39. NAICS 541714 is research and development in biotechnology (except nanobiotechnology), not nanobiotechnology R&D or a named California laboratory campus. Remove either filter and the number changes. This page never claims the pair caused the other side to exist. Correlation is not causation.

333 awards sit beside $226,140,894.39. Treating 333 as 333 California biotech laboratories would misread award records as people or plants. 333 rows can be a mix of vehicles, increments, and modifications rather than 333 campuses. Unique recipients are unpublished. Packet facts stop at $226,140,894.39, 333 awards, CA, and 541714.

Cross-check /states/ca/ if you need other NAICS in CA, /industries/541714/ if you need other states on this code, /states/ca/industries/ for the in-state code list, and /ties/ for other joins. Those URLs are parents and siblings, not addends for $226,140,894.39.

Biotechnology R&D except nanobiotechnology

Research And Development In Biotechnology (Except Nanobiotechnology) is the USAspending label on NAICS 541714. Speech often blends neighboring codes. This table does not. The industry is not nanobiotechnology R&D or a named California laboratory campus. $226,140,894.39 is 541714 only, inside California only. Award titles on /industries/541714/ are the place to see what a given line bought. This extract does not name jobsites or primes.

The packet lists no award recipients and no contractor names. Mixing this listing with other six-digit codes that share a CA tag would invent a combined total the packet never computed. Keep research and development in biotechnology (except nanobiotechnology) and California together when reading $226,140,894.39.

California as place of performance, not a campus map

California place of performance can cover Sacramento, Los Angeles, or San Diego, or a reporting address. The packet has no county split. Ordinary maps mention Sacramento, Los Angeles, or San Diego. This extract has no such split. All of those places, if they appear at all, share CA inside $226,140,894.39.

A California performance tag can sit on work whose parts, crews, or files moved through other states. The join reports the tag, not a bill of lading. /states/ca/ uses the same place-of-performance rule for every industry on the state hub. Headquarters can sit elsewhere.

333 award records on a nine-figure cell

About $679,101.78 per award comes from dividing $226,140,894.39 by 333. Use that ratio as a quotient across 333 records, not a typical research task order. 333 is not 333 California biotech laboratories. No median and no fiscal-year slice appear in the facts. 333 rows can be a mix of vehicles, increments, and modifications rather than 333 campuses.

What $226,140,894.39 will not prove

$226,140,894.39 is obligated, not necessarily paid. Outlays, cancellations, and fiscal-year buckets are unpublished. Do not upgrade the figure to California already received $226,140,894.39 in research and development in biotechnology (except nanobiotechnology) payments. Keep obligations as the verb. FEC donations do not fund these USAspending obligations.

A research and development in biotechnology (except nanobiotechnology) cell is not an employment ranking for California and not a claim that campaign contributions funded the awards. FEC filings and USAspending awards are different datasets. Keep $226,140,894.39 labeled as NAICS 541714 obligations with California place of performance.

How to cite 541714 in California

Quote USAspending.gov NAICS industry aggregates by place of performance state: Research And Development In Biotechnology (Except Nanobiotechnology) (541714) in California, $226,140,894.39, 333 awards, mean about $679,101.78. Point to /states/ca/ and /industries/541714/ as the unfiltered parents, /states/ca/industries/ as the state industry list, and /ties/ as other pairs. Leave population and years out; they are not packet facts.

Readers who reuse this snapshot should keep both sides of the join in the same sentence. Place of performance remains a geography tag, not proof that work stayed inside California. Keep Research And Development In Biotechnology (Except Nanobiotechnology) and California together when citing $226,140,894.39. NAICS 541714 and place-of-performance CA are the join keys. Obligations of $226,140,894.39 are not outlays. Original filings remain on USAspending.gov for this pair. Campaign-finance tables do not fund these USAspending obligations. Unique recipients remain unpublished on this state-industry join. A later USAspending ingest can restate $226,140,894.39 without changing the join keys. 333 is the award-record count, not 333 California biotech laboratories. About $679,101.78 is a quotient of two packet facts, not a typical invoice.

Questions

How much has NAICS 541714 obligated in California?
USAspending.gov records $226,140,894.39 in obligations for NAICS 541714 (Research And Development In Biotechnology (Except Nanobiotechnology)) with California place of performance, covering 333 awards. That is an obligation total, not an outlay total, and not the nationwide 541714 figure. Original filings remain on USAspending.gov.
Does California's 541714 total include nanobiotechnology R&D?
No. NAICS 541714 is research and development in biotechnology (except nanobiotechnology), not nanobiotechnology R&D or a named California laboratory campus. $226,140,894.39 does not absorb a named California vendor. Keep the six-digit code in the citation. Original filings remain on USAspending.gov. The pair is research and development in biotechnology (except nanobiotechnology) plus California only.
Do 333 awards mean 333 California biotech laboratories?
No. The extract lists 333 awards totaling $226,140,894.39. 333 rows can be a mix of vehicles, increments, and modifications rather than 333 campuses. Unique vendors are not published in this packet. About $679,101.78 is a quotient, not a typical invoice. Original filings remain on USAspending.gov.
Where is the live research and development in biotechnology (except nanobiotechnology)–California table?
California federal spending at /states/ca/ is the state rollup. NAICS 541714 at /industries/541714/ is the industry hub without a state filter. California industries at /states/ca/industries/ lists other NAICS in California. All spending ties at /ties/ lists other pairs. The $226,140,894.39 and 333 awards are the 541714×CA join only.

USAspending.gov NAICS industry aggregates by place of performance state. Obligations are not outlays.